Close

89bio Inc. (ETNB) Reports Positive Topline Results from ENTRIGUE Phase 2 Trial of Pegozafermin

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BA
8. BSX
9. SNAP
10. PI


Go back to 89bio Inc. (ETNB) Reports Positive Topline Results from ENTRIGUE Phase 2 Trial of Pegozafermin

89bio Reports Positive Topline Results from ENTRIGUE Phase 2 Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG)

June 28, 2022 4:01 PM EDT

- Trial met primary endpoint demonstrating statistically significant and clinically meaningful reductions across all doses (63% at the 27mg QW dose; p... More